Boston Scientific to buy Silk Road Medical for $1.16bln

Reuters Images

The companies said on Tuesday

Sriparna Roy, Reuters News

June 18, 2024

PHOTO

Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.

Silk Road Medical's technology helps prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization.

Boston will pay $27.50 for each share of Silk Road held, representing a premium of 27% to the stock's last close.

Shares of Silk Road Medical rose nearly 23% to $26.64 in premarket trading.

Boston Scientific expects to complete the transaction in the second half of 2024.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.